superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-12-31
- Valid until
- 2024-12-31
- Published
- 2024-02-05
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 3,990,700,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals operating income: 4,047,100,000 United States dollar", as of 2023-12-31 (until 2024-12-31). Claim clm_5B0035249BB7, https://asof.is/claim/clm_5B0035249BB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm.
APA
AsOf. (2023). Regeneron Pharmaceuticals operating income: 4,047,100,000 United States dollar (as of 2023-12-31 (until 2024-12-31)) [Record clm_5B0035249BB7]. Retrieved November 9, 2026, from https://asof.is/claim/clm_5B0035249BB7 (source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm)
BibTeX
@misc{asof_clm_5B0035249BB7,
author = {AsOf},
title = {Regeneron Pharmaceuticals operating income: 4,047,100,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_5B0035249BB7}},
note = {Claim clm\_5B0035249BB7, as of 2023-12-31 (until 2024-12-31); source: https://www.sec.gov/Archives/edgar/data/872589/000180422024000009/0001804220-24-000009-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_5B0035249BB7.md/v1/claims/clm_5B0035249BB7submit a correction